Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 10.75 CNY 0.94% Market Closed
Market Cap: 4.7B CNY
Have any thoughts about
Hunan Fangsheng Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Hunan Fangsheng Pharmaceutical Co Ltd stock under the Base Case scenario is 18.51 CNY. Compared to the current market price of 10.75 CNY, Hunan Fangsheng Pharmaceutical Co Ltd is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
18.51 CNY
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
22
vs Industry
38
Median 3Y
2.5
Median 5Y
2.3
Industry
2.5
Forward
2.6
vs History
79
vs Industry
18
Median 3Y
23.2
Median 5Y
30.3
Industry
21.8
Forward
19.4
vs History
28
vs Industry
17
Median 3Y
23.2
Median 5Y
17.7
Industry
16.1
vs History
7
vs Industry
21
Median 3Y
19.7
Median 5Y
20.8
Industry
23.8
vs History
15
vs Industry
23
Median 3Y
3
Median 5Y
2.4
Industry
2.1
vs History
19
vs Industry
34
Median 3Y
2.6
Median 5Y
2.4
Industry
2.7
Forward
3
vs History
22
vs Industry
42
Median 3Y
4
Median 5Y
3.6
Industry
5.2
vs History
68
vs Industry
13
Median 3Y
23.4
Median 5Y
23.9
Industry
13.5
Forward
13.5
vs History
68
vs Industry
17
Median 3Y
23.4
Median 5Y
23.9
Industry
16.8
Forward
17.2
vs History
28
vs Industry
16
Median 3Y
26
Median 5Y
19.9
Industry
15.2
vs History
31
vs Industry
11
Median 3Y
45.7
Median 5Y
31.5
Industry
19.3
vs History
14
vs Industry
37
Median 3Y
1.8
Median 5Y
1.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Hunan Fangsheng Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
4.7B CNY 2.7 17.3 21.3 21.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.1B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
348B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
150.1B USD 2.5 35.4 10.5 15.9
P/E Multiple
Earnings Growth P/E to Growth
CN
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Average P/E: 30.7
17.3
99%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Average EV/EBITDA: 415.7
21.3
170%
0.1
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Average EV/EBIT: 1 812.2
21.3
122%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top